In this video, Motley Fool health care analyst David Williamson takes a look at three biotech stocks making moves today and what you should know about them. Sequenom (NASDAQ: SQNM) made a big jump today despite higher-than-expected losses because of continued interest in its MaterniT21 Down syndrome test. SciClone Pharmaceuticals (SCLN +0.00%) released some disappointing numbers. And ISIS Pharmaceuticals (ISIS +1.57%) is up 15% after a recent buy rec from Cowen, but Williamson warns that there are some mitigating factors around ISIS that should curb investors' enthusiasm.
About the Author
The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...
Stocks Mentioned
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.




